Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.040x

Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion ≈ $56.06 Million USD) by net assets (Rp24.19 Trillion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kalbe Farma Tbk PT balance sheet independence to measure how much of total assets are equity-financed.

Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Kalbe Farma Tbk PT to evaluate the quality of earnings relative to operating cash generation.

Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Flight Centre Travel Group Ltd
AU:FLT
-0.051x
SIMMTECH Co. Ltd
KQ:222800
-0.092x
Shanghai Suochen Information Technology Co. Ltd. A
SHG:688507
N/A
Anhui Jiangnan Chemical Industry Co Ltd
SHE:002226
0.043x
Sino Horizon Holdings Ltd
TW:2923
-0.028x
Vimian Group AB
ST:VIMIAN
0.080x
Forvia SE
PA:FRVIA
0.366x
Shaanxi Huaqin Technology Industry Co. Ltd. A
SHG:688281
N/A

Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)

The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Kalbe Farma Tbk PT market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp24.59 Trillion
≈ $1.44 Billion
Rp4.79 Trillion
≈ $280.39 Million
0.195x +54.74%
2023-12-31 Rp23.12 Trillion
≈ $1.35 Billion
Rp2.91 Trillion
≈ $170.37 Million
0.126x -26.28%
2022-12-31 Rp22.10 Trillion
≈ $1.29 Billion
Rp3.77 Trillion
≈ $220.87 Million
0.171x +28.37%
2021-12-31 Rp21.27 Trillion
≈ $1.25 Billion
Rp2.83 Trillion
≈ $165.59 Million
0.133x -42.38%
2020-12-31 Rp18.28 Trillion
≈ $1.07 Billion
Rp4.21 Trillion
≈ $246.97 Million
0.231x +53.92%
2019-12-31 Rp16.71 Trillion
≈ $978.88 Million
Rp2.50 Trillion
≈ $146.66 Million
0.150x -17.30%
2018-12-31 Rp15.29 Trillion
≈ $896.20 Million
Rp2.77 Trillion
≈ $162.36 Million
0.181x +25.33%
2017-12-31 Rp13.89 Trillion
≈ $814.14 Million
Rp2.01 Trillion
≈ $117.68 Million
0.145x -16.59%
2016-12-31 Rp12.46 Trillion
≈ $730.33 Million
Rp2.16 Trillion
≈ $126.56 Million
0.173x -22.85%
2015-12-31 Rp10.94 Trillion
≈ $640.94 Million
Rp2.46 Trillion
≈ $143.97 Million
0.225x -4.79%
2014-12-31 Rp9.82 Trillion
≈ $575.27 Million
Rp2.32 Trillion
≈ $135.72 Million
0.236x +116.28%
2013-12-31 Rp8.50 Trillion
≈ $498.06 Million
Rp927.16 Billion
≈ $54.33 Million
0.109x -41.58%
2012-12-31 Rp7.37 Trillion
≈ $431.95 Million
Rp1.38 Trillion
≈ $80.65 Million
0.187x -17.44%
2011-12-31 Rp6.52 Trillion
≈ $381.81 Million
Rp1.47 Trillion
≈ $86.34 Million
0.226x +13.15%
2010-12-31 Rp5.77 Trillion
≈ $338.21 Million
Rp1.15 Trillion
≈ $67.60 Million
0.200x -29.78%
2009-12-31 Rp4.79 Trillion
≈ $280.71 Million
Rp1.36 Trillion
≈ $79.90 Million
0.285x +53.10%
2008-12-31 Rp4.34 Trillion
≈ $254.57 Million
Rp807.70 Billion
≈ $47.33 Million
0.186x +105.77%
2007-12-31 Rp4.02 Trillion
≈ $235.36 Million
Rp362.90 Billion
≈ $21.26 Million
0.090x -50.02%
2006-12-31 Rp3.54 Trillion
≈ $207.67 Million
Rp640.61 Billion
≈ $37.54 Million
0.181x +15.14%
2005-12-31 Rp2.81 Trillion
≈ $164.74 Million
Rp441.37 Billion
≈ $25.86 Million
0.157x -45.36%
2004-12-31 Rp1.48 Trillion
≈ $86.69 Million
Rp425.07 Billion
≈ $24.91 Million
0.287x -42.02%
2003-12-31 Rp1.02 Trillion
≈ $59.97 Million
Rp507.17 Billion
≈ $29.72 Million
0.496x -19.13%
2002-12-31 Rp651.41 Billion
≈ $38.17 Million
Rp399.13 Billion
≈ $23.39 Million
0.613x +25.47%
2001-12-31 Rp345.97 Billion
≈ $20.27 Million
Rp168.95 Billion
≈ $9.90 Million
0.488x +52.08%
2000-12-31 Rp305.74 Billion
≈ $17.91 Million
Rp98.17 Billion
≈ $5.75 Million
0.321x --

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General
Market Cap
$1.93 Billion
Rp32.85 Trillion IDR
Market Cap Rank
#6190 Global
#51 in Indonesia
Share Price
Rp725.00
Change (1 day)
+4.32%
52-Week Range
Rp665.00 - Rp1435.00
All Time High
Rp2271.54
About

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more